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Abstract
Background: Monocyte-derived macrophages contribute to atherosclerotic plaque formation. Therefore,
manipulating macrophage function could have significant therapeutic value. The objective of this study was to
determine transduction efficiency of two HIV-based lentiviral vector configurations as delivery systems for the
transduction of primary human blood monocyte-derived macrophages.
Results: Human blood monocytes were transduced using two VSV-G pseudotyped HIV-1 based lentiviral vectors
containing EGFP expression driven by either native HIV-LTR (VRX494) or EF1a promoters (VRX1090). Lentiviral
vectors were added to cultured macrophages at different times and multiplicities of infection (MOI). Transduction
efficiency was assessed using fluorescence microscopy and flow cytometry. Macrophages transduced between 2
and 120 hours after culturing showed the highest transduction efficiency at 2-hours transduction time.
Subsequently, cells were transduced 2 hours after culturing at various vector concentrations (MOIs of 5, 10, 25 and
50) to determine the amount of lentiviral vector particles required to maximally transduce human monocyte-
derived macrophages. On day 7, all transduced cultures showed EGFP-positive cells by microscopy. Flow
cytometric analysis showed with all MOIs a peak shift corresponding to the presence of EGFP-positive cells. For
VRX494, transduction efficiency was maximal at an MOI of 25 to 50 and ranged between 58 and 67%. For VRX1090,
transduction efficiency was maximal at an MOI of 10 and ranged between 80 and 90%. Thus, transductions
performed with VRX1090 showed a higher number of EGFP-positive cells than VRX494.
Conclusions: This report shows that VSV-G pseudotyped HIV-based lentiviral vectors can efficiently transduce
human blood monocyte-derived macrophages early during differentiation using low particle numbers that do not
interfere with differentiation of monocytes into macrophages.
Background
Coronary artery disease is the leading cause of death in
the United States and other Western societies [1]. Cor-
onary artery disease develops as a consequence of lipid
deposition and foam cell formation in the arterial wall
leading to the development of atherosclerotic plaques
[2]. Atherosclerosis is considered an inflammatory dis-
ease in which the major cell types implicated are macro-
phages, smooth muscle cells, and T lymphocytes [3].
Macrophages are present in virtually every atherosclero-
tic plaque and have an important role in foam cell and
atherosclerotic plaque formation through the uptake
and accumulation of cholesterol [4].
Circulating blood monocytes differentiate into macro-
phages. Monocytes can migrate through the blood vessel
wall into surrounding tissue, where they differentiate
into macrophages and accumulate in pathological tissue
sites in the body. Macrophages produce proinflamma-
tory and proangiogenic mediators, and function as host
cells for pathogens. Due to these functions, macro-
phages can contribute to the initiation and progression
of a wide variety of diseases. Therefore, directly manipu-
lating these hematopoietic cell subsets could have signif-
icant therapeutic value [5].
Human blood monocyte differentiation into macro-
phages can be induced in vitro using three different
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bovine serum (FBS) with granulocyte-macrophage col-
ony-stimulating factor (GM-CSF) or 3) FBS with macro-
phage colony-stimulating factor (M-CSF). In our
experience, macrophages differentiated with HS or GM-
CSF with FBS show similar phenotype and morphology
(i.e., round cells resembling fried eggs) [6,7]. However,
the M-CSF differentiated monocyte-derived macrophage
has a different phenotype characterized by an elongated
shaped macrophage with numerous vacuoles corre-
sponding to macropinosomes, and constitutive uptake of
low-density lipoprotein (LDL) [8,9].
Gene transfer methods have been attempted to manipu-
late gene expression in macrophages. Non-viral methods
such as calcium phosphate precipitation, electroporation,
and liposomal or polyethylenimine transfection are less
time-consuming and allow use of a larger number of con-
structs per experiment than viral methods. However non-
viral gene transfer methods are inefficient at transfecting
macrophages [5]. Viral systems generally give higher gene
transfer efficiency and longer expression time than non-
viral systems, but only allow the transfer of small sizes
(less than 8 kb) of foreign DNA [10]. Viral methods using
adenoviruses have reported high transduction efficiency,
but their lack of integration into the host cell genome
makes the expression of any transferred gene transient
[11-14]. Retroviruses (except lentivirus) require cell divi-
sion to integrate their DNA into the host genome to
remain stably transduced [15]; therefore, the limited prolif-
erative nature of primary human macrophages does not
favor the use of this viral vector.
Lentiviruses like HIV have the capacity to infect non-
dividing and dividing cells and to integrate into the host
cell genome [16-20]. Due to these characteristics, HIV-
based lentiviral vectors have been proposed as good
delivery system candidates for gene therapy, but the
attempt to use them in clinical trials has raised concerns
about their safety including the risk of genetic recombi-
nation leading to the generation of replication-compe-
tent retrovirus in humans. Further modifications in the
packaging and genetic components of viral genes have
been carried out to develop safer HIV-based lentiviral
vector systems [21-24]. Due to our interest in gene
manipulation of human M-CSF differentiated monocyte-
derived macrophages, the objective of this study was to
determine transduction efficiency of primary human
blood M-CSF differentiated monocyte-derived macro-
phages transduced with two VSV-G pseudotyped HIV-1
based lentiviral delivery systems.
Results
Determination of optimal time to transduce
Macrophage cultures from the same donor (donor 1)
were transduced with VRX1090 vector using an MOI of
50 (final concentration of 30 × 10
6 transducing units
per ml, TU/ml) at 2, 24, 48 and 120 hours after plating.
On day 8, all cultures transduced with VRX1090 showed
EGFP-positive cells by microscopic examination (Figure
1A). In addition, cell density assessed by phase micro-
scopy was slightly decreased in cultures transduced at
24, 48 and 120 hours compared with 2 hours after plat-
ing. Flow cytometric analysis carried out on day 9
showed a peak shift in data histograms corresponding to
the presence of EGFP-positive cells for all transduced
cultures compared with non-transduced control cells
(Figure 1A). These findings correlated with the qualita-
tive results found by direct visualization of the cells with
the fluorescence microscope. All transductions were
highly efficient with values between 66 and 92% of cells
showing EGFP fluorescence. There was a negative corre-
lation (r = -0.99, p = 0.013) between time of transduc-
tion and % EGFP-positive cells.
The results showed that the highest transduction effi-
ciency was reached when monocytes were transduced 2
hours after plating. On the other hand, the amount of
fluorescence intensity per cell did not correlate (r =
0.46, p = 0.54) with time of transduction (Figure 1B).
Considering these findings, in order to achieve the high-
est transduction efficiency, all following experiments
were performed 2 hours after monocyte plating.
Determination of optimal multiplicity of infection
We next determined the MOI required during transduc-
tion to efficiently transduce human monocyte-derived
macrophages. In the experiment shown in figures 2, 3
and 4A, macrophage cultures from donor 2 were trans-
duced once at the optimal transduction time, determined
above to be 2 hours after plating. Transduction was per-
formed using two different lentivirus vectors VRX494
and VRX1090. Each transduction was carried out using
different MOIs: 5, 10, 25, and 50 at a final concentration
of 3, 6, 15, and 30 × 10
6 TU/ml, respectively.
On day 7, all VRX494-transduced cultures showed
EGFP-positive cells (Figure 2). On day 8, % EGFP-posi-
tive cells and fluorescence intensity were quantified
using flow cytometry. In all transduced cultures a peak
shift corresponding to the presence of EGFP-positive
cells was found (Figure 3). Transduction efficiency ran-
ged between 8 and 58%, and a positive correlation (r =
0.99, p = 0.007) between MOI and % EGFP-positive
cells was found. However, the fluorescence intensity per
cell showed a trend toward lower values with higher
MOIs used for transduction (Figure 4A).
Photomicrographs of cultures transduced with VRX1090
showed EGFP-positive cells in all conditions (Figure 2).
However, at an MOI of 25 and 50 a decrease in cell den-
sity compared to non-transduced control was observed by
phase microscopy. On day 8, flow cytometry analysis was
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Page 2 of 10Figure 1 EGFP expression and flow cytometry analysis of human blood monocyte-derived macrophages transduced at different times.
Cells from donor 1 were transduced with lentivirus VRX1090 using an MOI of 50 (30 × 10
6 transducing units/ml) at 2 (B), 24 (C), 48 (D) and 120
(E) hours after cell plating. Control non-transduced cells are shown in A. Each row of the upper panel corresponds to the same microscopic field
and respective flow cytometry histogram. Photomicrographs were taken on day 8 after cell plating. Scale bar = 50 μm and applies to all. Each
bracketed region in the histogram corresponds to % EGFP-positive cells and shaded area corresponds to non-transduced cell control. Flow
cytometry was performed on day 9 after cell plating. Shown in lower panel is mean fluorescence intensity per EGFP-positive cell at different
times after cell plating.
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Page 3 of 10performed. Since the cell density of the culture transduced
with an MOI of 50 was very low, there were insufficient
cells for flow cytometry analysis. In all conditions, flow
cytometry analysis histograms showed a peak shift for
transduced cells when compared with non-transduced
cells (Figure 3). All transductions were highly efficient
with a range between 56 and 80% EGFP-positive cells.
However, % EGFP and mean fluorescence intensity per
cell showed no correlation with the MOIs used for trans-
duction (Figures 3 and 4A).
To evaluate the role of the donor in the variability of
these results, a second experiment using VRX1090 and
VRX494 and different MOIs was repeated using blood
monocytes from a different donor (donor 3). As shown
in Table 1 and Figure 4B, the results obtained for each
vector such as % EGFP-positive cells and mean fluores-
cence intensity per cell trends were generally similar to
the first experiment with donor 2. Also, vector copy
numbers per cell were determined in this experiment
and generally correlated with % EGFP-positive cells
(Table 1). Cultures transduced at MOIs of 25 and 50
showed low cell density, and following flow cytometry
there were not enough cells remaining for determination
of vector copy numbers.
Discussion
Primary cells are usually more difficult to transfect or
transduce than their similar immortalized cell lines [25],
and macrophages are one of the most resistant cell
types to gene transfer [10]. Therefore, obtaining efficient
gene transfer in primary human blood monocyte-derived
macrophages could be challenging.
In this report, we found that the best time to trans-
duce human blood monocytes was 2 hours after cell
plating. There were progressively fewer EGFP-positive
cells when macrophage cultures were transduced at later
times following plating of the cells. The differences
between transduction time and time of flow cytometry
quantification probably do not explain the negative cor-
relation found between time of transduction and %
Figure 2 EGFP expression in human blood monocyte-derived macrophages transduced with VRX494 and VRX1090 at different MOIs.
Cells from donor 2 were transduced with lentivirus 2 hours after plating using MOIs of 5 (B), 10 (C), 25 (D), and 50 (E) at a final concentration of
3, 6, 15, and 30 × 10
6 transducing units/ml, respectively. Control non-transduced cells are shown in A. Each row corresponds to the same
microscopy field. Photomicrographs were taken on day 7 after cell plating. Scale bar = 50 μm and applies to all.
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Page 4 of 10Figure 3 Flow cytometry analysis of human blood monocyte-derived macrophages transduced with lentivirus at different MOIs. Cells
from donor 2 were transduced with lentivirus VRX494 and VRX1090 two hours after plating using MOIs of 5 (A), 10 (B), 25 (C), and 50 (D) at a
final concentration of 3, 6, 15, and 30 × 10
6 transducing units/ml, respectively. Each bracketed region in the histogram corresponds to % EGFP-
positive cells and shaded area corresponds to non-transduced cell control. Flow cytometry was performed on day 8 after cell plating.
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Page 5 of 10EGFP positive cells. EGFP is a stable protein with a
turnover of approximately 10% in 3 hours, whose
expression can be detected 24-48 hours after its cDNA
has been transferred into various mammalian cell types
[26]. Since all transductions in our cell cultures were
performed between 72 hours and 192 hours before
quantification, it is reasonable to conclude that by the
time of flow cytometry quantification, all transduced
cultures should have already reached their plateau of
EGFP concentration. Thus, the difference observed
between each group was likely due to differences in
transduction efficiency rather than due to the differences
in time of flow cytometry quantification. These findings
suggest that monocyte-derived macrophages during the
e a r l yp h a s e so fd i f f e r e n t i a t i o na r eh i g h l yt r a n s d u c i b l e
with VRX1090, but later they become less susceptible to
transduction; the less differentiated the higher the
transduction efficiency. However, we cannot exclude the
possibility that more differentiated macrophages trans-
duced for longer times would produce higher transduc-
tion efficiencies. In any case, transduction at later times
after cell plating was associated with lower macrophage
cell density, another factor favoring transduction at
2 hours after plating as the optimal time for transduction.
The possibility that macrophages phagocytosed EGFP
derived from lentiviral solution contaminated with
EGFP expressed during generation of the lentivirus from
infected producer cells (i.e., pseudotransduction) cannot
explain these findings. In such a case, the results would
have been the opposite. In pseudotransduction, cells
initially take up EGFP but then metabolize it without
producing new EGFP. Thus, in pseudotransduction the
cultures that were transduced later should have shown a
higher proportion of EGFP-positive cells. Since this is
the opposite of the pattern observed in this experiment,
pseudotransduction was probably minimal.
Cultures transduced 24, 48 and 120 hour after plating
showed a decrease in cell density when compared with
the non-transduced control cultures transduced at
2-hours after plating. Since all cultures transduced 24
hours after plating were in the process of macrophage
differentiation [27], it is possible that lentivirus addition
in these cultures decreased cell proliferation or affected
the differentiation of monocytes into macrophages to
some degree thereby indirectly decreasing macrophage
survival. The possibility of direct lentivirus-induced cell
toxicity is remote, because it is well established that
cell-induced toxicity correlates with exposure time. In
our experiments, the culture with the longest exposure
time to the lentivirus was the culture transduced
2 hours after plating. This culture showed the highest
cell density compared with the other transduced cul-
tures, so direct lentivirus-induced cell toxicity cannot
explain the decrease in cell density. Mean fluorescence
Figure 4 Transduction efficiency of human blood monocyte-
derived macrophages transduced with VRX494 and VRX1090
at different MOIs. Transduction efficiency as represented by mean
fluorescence intensity per EGFP-positive cell of human blood
monocyte-derived macrophages from donor 2 (A) and donor 3 (B)
transduced with lentivirus VRX494 and VRX1090 at different MOIs.
Flow cytometry was performed on day 8 after cell plating.
Table 1 Transduction efficiency of human blood
monocyte-derived macrophages using different MOIs
MOI % EGFP-positive cells G-tag copies per cell
VRX494
52 3 9
10 39 18
25 67 nd*
50 56 nd
VRX1090
58 33 7
10 90 55
25 74 nd
50 44 nd
*nd = not determined due to low cell number Human blood monocyte-
derived macrophages for this experiment were obtained from donor 3.
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Page 6 of 10intensity per cell did not correlate with transduction
time, suggesting that the amount of EGFP expressed per
transduced cells is independent of transduction and
macrophage differentiation time.
Our findings show that both lentiviruses at any of the
various concentrations used were able to transduce
monocyte-derived macrophages and produce EGFP in
amounts sufficient for detection. Results of transducing
monocyte-derived macrophages with VRX494 were
similar to those observed in previous reports using viral
transducing systems, higher MOIs resulted in higher fre-
quency of cells that were transduced [20,28,29]. Trans-
ductions performed with VRX1090 showed a higher
frequency of transduced cells than VRX494, but cells
transduced with VRX494 showed higher fluorescence
intensity per cell. These differences could be explained
mostly by macrophage response during transduction
(e.g., activation, promoter expression). Since each
lentiviral vector used in this study requires a different
promoter for protein expression, it is possible that dif-
ferences in promoter and cell activity could have been
responsible of the differences in the levels of EGFP
expression. There is less possibility that intrinsic differ-
ences between the 2 lentiviruses (e.g., particle size, stabi-
lity) could explain the differences found between both
vectors since the same system was used to generate
both lentiviruses.
Previous publications evaluating different viral systems
for gene transfer in primary human monocyte-derived
macrophages used the three methods previously men-
tioned to induce cell differentiation: HS, M-CSF and
GM-CSF [13,30,31]. Table 2 shows the transduction effi-
ciency (measured as frequency of positive cells), its
quantification technique, viral system used, MOI, and
blood monocyte-derived macrophage differentiation
method reported by each publication [12-14,19-21,
28-34]. Only our study using HIV-derived lentivirus
reached higher values comparable to those studies in
Table 2 using adenovirus viral systems that required
higher MOIs and as discussed above without viral DNA
incorporation into the host cell genome which is required
for stable transduction. However, when comparing our
study with previous studies listed in Table 2 where HIV-
derived lentivirus was used to transduce human macro-
phages [19-21,28,29,32,34], only in our study was M-CSF
used to induce macrophage differentiation. M-CSF-dif-
ferentiated macrophages have been reported to show
higher transduction efficiency than GM-CSF-differen-
tiated macrophages when adenovirus viral systems are
used [30]. This last finding is expected since adenovirus
requires integrin avb5 for internalization [35], and
M-CSF-differentiated macrophages express higher levels
of integrin avb5 than GM-CSF-differentiated macro-
phages [30]. VSV-G pseudotyped lentiviral vectors, such
as the ones used in this report, have very broad tropism
for cell infection [36]. However, it is possible that the
transduction efficiency differences observed when com-
paring M-CSF with GM-CSF-differentiated macrophages
may be due to differences in mechanisms available for
uptake of VSV-G pseudotyped lentivirus by these two
types of macrophages. In this regard, M-CSF differen-
tiated human macrophages show very high levels of con-
stitutive fluid-phase pinocytosis mediated by both
macropinocytosis and micropinocytosis [8,9]. Fluid-phase
pinocytosis (a non-receptor uptake mechanism) has been
shown to mediate enhanced cellular transduction by
Table 2 Transduction efficiency* of human blood monocyte-derived macrophages using different viral systems
Transduction
efficiency
MOI Viral system Differentiation
Method
Quantification technique
Haddada H, et al. [13] 40-80% 100 Adenovirus HS Beta-gal activity
Huang S, et al. [30] 52% 1000 Adenovirus M-CSF+FBS Beta-gal activity
Schneider SD, et al. [33] 20% 100 Adenovirus HS LacZ activity
De S, et al. [31] 10% 100 Adenovirus GM-CSF+FBS Beta-gal activity
Foxwell B, et al. [12] > 90% 100 Adenovirus M-CSF+FBS Beta-gal activity flow cytometry
Heider H, et al. [14] 80% 30 Adenovirus HS GFP fluorescence microscopy
White S, et al. [34] 15% 1 HIV/SIV based lentivirus GM-CSF+HS GFP fluorescence microscopy
Schroers R, et al. [20] 30% 100 HIV based lentivirus GM-CSF+FBS YFP flow cytometry
Neil S, et al. [19] 20% 10 HIV based lentivirus HS GFP flow cytometry
Ravot E, et al. [32] 40% 0.65 HIV based lentivirus HS+FBS GFP flow cytometry
Lu Y, et al. [21] 40% 50 HIV based lentivirus HS+FBS GFP fluorescence microscopy
Jarrosson-Wuilleme L, et al. [28] 30% 25 HIV based lentivirus GM-CSF+FBS GFP flow cytometry
Zeng L, et al. [29] 50% 100 HIV based lentivirus HS+FBS GFP fluorescence microscopy
Current report 80-90% 10 HIV based lentivirus M-CSF+FBS EGFP flow cytometry
* Percentage transduced cells, values correspond to the highest value listed in the respective manuscript. MOI = multiplicity of infection, HS = human serum,
GM-CSF = granulocyte-macrophage colony-stimulating factor, M-CSF = macrophage colony-stimulating factor, FBS = fetal bovine serum.
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Page 7 of 10vesicular stomatitis virus pseudotyped vectors as well as
uptake of HIV by M-CSF differentiated human macro-
phages [37,38].
Our finding that the optimal time to transduce M-CSF
differentiated macrophages was better when these
macrophages were less differentiated contrasts with the
previous findings reported by Zeng et al. [29] in which less
differentiated macrophages were more resistant to trans-
duction. However, Zeng et al. reported transducing
macrophages following differentiation with human serum,
which produces the GM-CSF macrophage phenotype in
contrast to the M-CSF macrophage phenotype we have
studied here. Zeng et al. also transduced the macrophages
in the presence of polybrene. We did not use polybrene in
our experiments because we observed that polybrene was
toxic to human M-CSF differentiated monocyte-derived
macrophages (unpublished observation).
Conclusions
If higher MOIs are excluded, where donor-dependent a
cell density decrease was usually observed, our study
shows that transducing M-CSF differentiated monocyte-
derived macrophages with VRX1090 lentivirus using an
MOI of 10 consistently gives 80-90% transduction effi-
ciency with no observed decrease in cell density. Thus,
we show for first time that HIV-based lentiviruses can
efficiently transduce M-CSF differentiated human blood
monocyte-derived macrophages early during differentia-
tion using a low MOI that will not interfere with the
cell differentiation process or induce a decrease in cell
density.
Methods
Cell Culture
Human blood monocytes were collected from three
healthy blood donors (donor 1, 2 and 3) and purified
with counterflow centrifugal elutriation of mononuclear
cells [39]. Human blood cell collections were done by
the Department of Transfusion Medicine, Clinical Cen-
ter, National Institutes of Health, under a human sub-
jects research protocol approved by a National Institutes
of Health institutional review board and in agreement
with the Helsinki Declaration. Cells were plated at 2 ×
10
5 cells per cm
2 in 6-well CellBIND plates (Corning,
Corning, NY), and cultured in RPMI 1640 medium
(Mediatech, Herndon, VA) with 10% FBS (Invitrogen,
Carlsbad, CA). After 2-hours in a cell culture incubator
with 5% CO2/95% air at 37ºC, cells were rinsed 3 times
with RPMI 1640 medium and then cultured in 3 ml
RPMI 1640 medium with 10% FBS, 50 ng/ml M-CSF,
and 25 ng/ml IL-10, both of the latter obtained from
PeproTech (Rocky Hill, NJ). IL-10 was used to induce
differentiation of monocytes into macrophages, since IL-
10 used together with M-CSF increases M-CSF receptor
expression which enhances the macrophage differentia-
tion process [27]. Cell cultures were fed with fresh med-
ium after five days.
Vector production
Two vesicular stomatitis virus G protein (VSV-G) pseu-
dotyped HIV-1 based lentiviral vectors encoding the
enhanced green fluorescent protein (EGFP) driven by
either the native HIV LTR promoter (VRX494, derived
from NL4-3, Clade B) or the constitutive EF1a promo-
ter in a SIN configuration (VRX1090), both produced by
VIRxSYS Corporation (Gaithersburg, MD) were used for
these studies. Vectors were produced as previously
described [40,41]. In brief, HEK293 cells were trans-
fected using calcium phosphate with the VIRPAC packa-
ging construct, a single packaging plasmid that co-
expresses Gag-Pol, Tat, Rev, and VSV-G. Supernatant
containing lentiviral particles were collected every 12 h
from 24 to 48 h after transfection, concentrated by
high-speed centrifugation at 10,000 g for 12 h, and
titered by Q-PCR (determination of number of transdu-
cing or infectious units per ml) on HeLa-tat cells. Titers
for VRX494 and VRX1090 were 3 × 10
9 TU/ml (p24 =
47 ug/ml) and 3.9 × 10
9 TU/ml (p24 = 92 ug/ml)
respectively.
Transduction of macrophages
Cultured monocyte-derived macrophages were trans-
duced separately with lentiviral vectors VRX494 and
VRX1090. Lentiviral vectors were added directly into
each well containing 3 ml of culture medium at different
Hela-tat based multiplicities of infection (MOI-defined
as the number of lentiviral particles able to transduce
used per Hela-tat cell). Macrophage transduction effi-
ciency, defined as percentage of transduced cells expres-
sing EGFP and mean fluorescence intensity, was
assessed qualitatively using an Olympus IX81 fluores-
cence microscope (Center Valley, PA) equipped with an
FITC filter, and quantitatively using a FACSCalibur flow
cytometer (Becton Dickinson Biosciences, San Jose, CA).
Because a cell suspension was required for flow cytome-
try analysis, cells were scraped from each well after a 5-
minute incubation with Cellstripper solution (Media-
tech), a non-enzymatic cell dissociation mixture of che-
lators. Non-transduced cells serving as controls also
were analyzed with the cytometer. Gating was set on
light scatter to include cells while excluding debris.
EGFP fluorescence was measured using the 525 nm
bandpass channel. EGFP positive cells were defined as
those cells having fluorescence intensity greater than the
non-transduced control cells. The mean geometric
fluorescence intensity per EGFP-positive cell was deter-
mined. Data were analyzed using FCS Express version 3
(De Novo Software, Los Angeles, CA).
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Transduced monocyte-derived macrophages were
scraped from each well after a 5-minute incubation with
Cellstripper solution (Mediatech). Total genomic DNA
was extracted and purified using a QIAamp DNA Micro
Kit from Qiagen (Valencia, CA). Vector-specific real-
time PCR analysis using primers and probes specific for
GFP cDNA (G-tag) were carried out to determine the
number of integrated viral genomes. Cell numbers were
estimated by measuring the number of b-globin DNA
copies per sample by real-time PCR as previously
described [42].
Statistical Analysis
Data was analyzed using Pearson’s correlation coeffi-
cient. Statistical analyses were performed using Prism 4
for Windows version 4.00 (GraphPad Software, Inc., La
Jolla, CA). Alpha error was set at p < 0.05.
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